Organization · Private Equity
Triple Helix Capital
Triple Helix Capital is an investment management firm based in the Dubai International Financial Centre, focusing on strategic investments in healthcare, biotechnology, and technology sectors. The firm aims for a target annual return of 25% or more through its investments in private and pre-IPO companies.
Overview
What Triple Helix Capital does
What Triple Helix Capital is
Triple Helix Capital is an investment management firm based in the Dubai International Financial Centre, focusing on strategic investments in healthcare, biotechnology, and technology sectors. The firm aims for a target annual return of 25% or more through its investments in private and pre-IPO companies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Founded
- Founded in 2022
- Approximate age
- About 4 years
- Structured capabilities
- Funder
- Last reviewed
- April 4, 2026
Official channels
Find Triple Helix Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Triple Helix Capital as a funder
Investment thesis
Triple Helix Capital aims to generate value for its shareholders and investors through strategic investments in various sectors, particularly in digital healthcare, biotechnology, education, and technology.
Focus narrative
Triple Helix Capital invests in private and pre-IPO companies across the globe, with a target annual return of 25% or more. The company focuses on the healthcare, biotech, and technology sectors. The investment style includes growth, event-driven, and special situations, with a holding period of 3 to 5 years. The indicative investment ticket size ranges from $5 million to $15 million, emphasizing social impact and Shariah compliance.
Value beyond capital
Triple Helix Capital emphasizes social impact and Shariah compliance in its investment approach, aiming to generate significant returns while contributing positively to society.
Terms and economics
- Typical check
- $5,000,000–$15,000,000
Focus and fit
- Stages
- Pre-IPO · Growth Equity
- Regions
- Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded notable exits
- Moderna and Verily
Portfolio context
The organization has a notable track record in the biotechnology and healthcare sectors, having invested in companies such as Moderna, an early investment in the mRNA technology company, which has seen significant growth, especially during the COVID-19 pandemic, and Verily, a subsidiary of Alphabet focused on disease detection and treatment technologies, which has also achieved notable success.
Common questions
What to know about Triple Helix Capital
Upseed classifies Triple Helix Capital under the Private Equity organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 4, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.